Tools to implement and improve blood donor hemovigilance in Brazil.
作者信息
de Almeida Cesar
机构信息
Fundação Pró-Sangue , Hemocentro de São Paulo, São Paulo, SP, Brazil, Fundação Pró-Sangue - Hemocentro de São Paulo, São Paulo, SP, Brazil.
出版信息
Rev Bras Hematol Hemoter. 2014 Mar;36(2):106-7. doi: 10.5581/1516-8484.20140025.
Abstract
摘要
相似文献
1
Tools to implement and improve blood donor hemovigilance in Brazil.
Rev Bras Hematol Hemoter. 2014 Mar;36(2):106-7. doi: 10.5581/1516-8484.20140025.
2
Proposing a Model for the National Hemovigilance Information System in Iran.
J Med Life. 2020 Apr-Jun;13(2):211-218. doi: 10.25122/jml-2019-0112.
3
Hemovigilance in developing countries.
Biologicals. 2010 Jan;38(1):91-6. doi: 10.1016/j.biologicals.2009.10.002. Epub 2010 Feb 4.
4
Clinical Assessment of Nursing Care Regarding Hemovigilance in Neonatal Wards and Neonatal Intensive Care Units in Selected Hospitals Affiliated to Shahid Beheshti University of Medical Sciences (2013 - 2014).
Iran Red Crescent Med J. 2015 Jul 22;17(7):e19987. doi: 10.5812/ircmj.19987v2. eCollection 2015 Jul.
5
Transfusion-related adverse reactions: From institutional hemovigilance effort to National Hemovigilance program.
Asian J Transfus Sci. 2016 Jan-Jun;10(1):31-6. doi: 10.4103/0973-6247.175391.
6
The best blood product and its best use for each patient: An evolving role for hemovigilance?
Transfus Clin Biol. 2019 Sep;26(3):188-191. doi: 10.1016/j.tracli.2019.04.001. Epub 2019 May 15.
7
How is national recipient hemovigilance conducted in the United States?
Transfusion. 2015 Apr;55(4):703-7. doi: 10.1111/trf.12980. Epub 2015 Jan 7.
8
[Implementation of hemovigilance in Sub-Saharan Africa].
Transfus Clin Biol. 2012 Feb;19(1):39-45. doi: 10.1016/j.tracli.2011.11.001. Epub 2012 Jan 30.
9
Hemovigilance: A new beginning in India.
Int J Appl Basic Med Res. 2015 Sep-Dec;5(3):200-2. doi: 10.4103/2229-516X.165379.
10
The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study.
Transfusion. 2021 Sep;61(9):2668-2676. doi: 10.1111/trf.16572. Epub 2021 Jul 6.
本文引用的文献
1
Translation into Portuguese and validation of the Blood Donation Reactions Inventory.
Rev Bras Hematol Hemoter. 2014 Mar;36(2):139-46. doi: 10.5581/1516-8484.20140031.
2
Vasovagal reactions in whole blood donors at three REDS-II blood centers in Brazil.
Transfusion. 2012 May;52(5):1070-8. doi: 10.1111/j.1537-2995.2011.03432.x. Epub 2011 Nov 11.
3
Adverse reactions and other factors that impact subsequent blood donation visits.
Transfusion. 2012 Jan;52(1):118-26. doi: 10.1111/j.1537-2995.2011.03216.x. Epub 2011 Jun 17.
4
Interventions to reduce the vasovagal reaction rate in young whole blood donors.
Transfusion. 2011 Jul;51(7):1511-21. doi: 10.1111/j.1537-2995.2011.03074.x. Epub 2011 Mar 7.
5
Psychometric properties of the Blood Donation Reactions Inventory: a subjective measure of presyncopal reactions to blood donation.
Transfusion. 2008 Sep;48(9):1820-6. doi: 10.1111/j.1537-2995.2008.01831.x. Epub 2008 Jul 24.
6
Opinions about donating blood among those who never gave and those who stopped: a focus group assessment.
Transfusion. 2007 Apr;47(4):729-35. doi: 10.1111/j.1537-2995.2007.01177.x.
Zotero 插件